Company Filing History:
Years Active: 2016-2019
Title: Innovations by Carla Agurto in Retinal Imaging Technology
Introduction
Carla Agurto is an accomplished inventor based in Albuquerque, NM (US). She has made significant contributions to the field of retinal imaging technology, holding 2 patents that focus on improving the quality and accessibility of eye disease screening.
Latest Patents
Her latest patents include systems and methods for automatic processing of digital retinal images in conjunction with an imaging device. These innovations involve obtaining and recording fundus images by minimally trained individuals. The system incorporates a camera designed to capture images of the fundus of a subject's eye, combined with mathematical methods that assign real-time image quality classifications based on specific criteria. The classified images undergo further processing if they meet the quality standards necessary for clinical interpretation, utilizing both machine-coded and human-based methods. This technology can automatically assess whether a retinal image is suitable for computer-based eye disease screening. The system integrates global histogram features, textural features, and vessel density, along with a local non-reference perceptual sharpness metric. A partial least square (PLS) classifier is trained to differentiate between low-quality and normal-quality images.
Career Highlights
Carla Agurto is currently associated with Visionquest Biomedical LLC, where she continues to innovate in the field of biomedical imaging. Her work is pivotal in enhancing the capabilities of retinal imaging systems, making them more user-friendly and effective for clinical applications.
Collaborations
Some of her notable coworkers include Simon Barriga and Honggang Yu, who contribute to the collaborative efforts in advancing retinal imaging technologies.
Conclusion
Carla Agurto's work in retinal imaging technology exemplifies the impact of innovation in healthcare. Her patents are a testament to her dedication to improving eye disease screening processes, making significant strides in the field.